Skip to main content

Medical Oncology

Ausgabe 7/2021

Inhalt (12 Artikel)

Original Paper

Melittin inhibits the expression of key genes involved in tumor microenvironment formation by suppressing HIF-1α signaling in breast cancer cells

Zabih Mir Hassani, Mohammad Nabiuni, Kazem Parivar, Somayeh Abdirad, Latifeh Karimzadeh

Original Paper

Systematic identification of the cancer pathways and molecules related with breast cancer immunogenicity

Xiaoli Wang, Silu Xu, Lingli Huang, Lei Wang, Nan Wu

Original Paper

Biological activity and molecular docking studies of some new quinolines as potent anticancer agents

Tuğba Kul Köprülü, Salih Ökten, Vildan Enisoğlu Atalay, Şaban Tekin, Osman Çakmak

Original Paper

ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma

Li Chen, Weijie Zou, Lei Zhang, Huijuan Shi, Zhi Li, Caifang Ni

Review Article

Triple-arm androgen blockade for advanced prostate cancer: a review

Milap H. Desai, Meghana Parsi, Rashmika R. Potdar

Review Article

Cancer stem cell characteristics and their potential as therapeutic targets

Jacqueline R. Lim, Josette Mouawad, Olivia K. Gorton, William A. Bubb, Ann H. Kwan

Review Article

Immunotherapy era in the treatment of small cell lung cancer

Murat Araz, Melek Karakurt Eryilmaz

Letter to the Editor

How should we manage non-small-cell lung cancer “not-otherwise-specified”?

Young Hak Kim, Yoshihiro Nishimura, Yasuhiro Funada

Correction

Correction to: Diosmetin induces apoptosis in ovarian cancer cells by activating reactive oxygen species and inhibiting the Nrf2 pathway

Feijie Zhao, Xiaoling Hong, Danjie Li, Zhentong Wei, Xinxin Ci, Songling Zhang

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.